Advertisement
ECG vs PWR
Which Stock Would AI Choose? Everus Construction Group (ECG) vs. Quanta Services (PWR) Stock Comparison
Key Takeaways
- ECG is a recently spun-off, small-cap specialty contractor riding data center and utility demand, while PWR is a diversified large-cap infrastructure leader with a much larger backlog.
- Both stocks are levered to the same secular theme — AI-driven power demand and grid modernization — but at very different scales and valuations.
- ECG has shown explosive earnings growth and record backlog, though it carries the volatility of a newly independent company.
- PWR trades at a substantial earnings-multiple premium and has cooled after a strong run, despite its record $48.5 billion backlog.
- The comparison is fundamentally one of higher-growth, higher-volatility exposure versus scale, stability, and a richer valuation.
Introduction
Investors scanning the infrastructure and electrical contracting space frequently encounter two names that, on the surface, serve similar end markets yet operate on entirely different scales. Everus Construction Group (ECG) is a recently established independent company focused on electrical and mechanical (E&M) and transmission and distribution (T&D) contracting, while Quanta Services (PWR) is North America's largest specialty contractor. Both are beneficiaries of AI-driven data center power demand and grid investment, which makes their relative performance and market positioning a useful case study for growth-oriented and value-conscious investors alike.
ECG Overview and Recent Performance
Everus Construction Group (ECG) was spun off from MDU Resources and began trading independently in 2024. The company provides electrical, mechanical, and transmission and distribution services to commercial, industrial, institutional, renewables, and utility customers across the United States, with data center construction a key growth driver in its E&M segment.
In recent market activity, ECG has delivered standout operational results. Its most recent quarterly report showed record revenue of roughly $1.23 billion, up more than 33% year over year, with net income rising nearly 59% and diluted earnings per share (EPS, or profit allocated to each outstanding share) reaching $1.64. Backlog climbed to a record $4.55 billion, up about 53% from the prior-year period. Management raised its full-year guidance on the back of this momentum, supported by acquisitions including SE&M Constructors and a planned purchase of Epsilon Industries. Net leverage remains low at roughly 0.3x, giving the company flexibility for further deal-making.
Sentiment has been broadly constructive, with several analysts raising price targets. However, the shares remain volatile relative to the broader market, reflecting both the company's rapid growth and its status as a recently independent, small-cap name.
PWR Overview and Recent Performance
Quanta Services (PWR) is the largest specialty infrastructure contractor in North America, providing integrated solutions across electric power, energy, communications, and pipeline markets through operations in the United States, Canada, Australia, and select international markets. Its scale and skilled workforce position it to execute large, complex transmission, distribution, and load-center (data center) projects.
Recent quarters have been strong for PWR. The company reported first-quarter revenue of approximately $7.87 billion, up more than 26% year over year, with adjusted diluted EPS of $2.68 and record adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of about $686 million. Total backlog reached a record $48.5 billion, and remaining performance obligations (RPO, the contracted revenue not yet recognized) hit $26.2 billion. Management raised substantially all of its full-year expectations.
Despite robust fundamentals, the stock has been choppier in recent weeks after a strong multi-year run. Shares trade at a premium earnings multiple, and a recent pullback has trimmed year-to-date gains even as analyst sentiment remains largely positive, with the consensus rating near "Strong Buy."
Trending AI Robots
Tickeron maintains a large library of AI trading bots that collectively monitor and trade thousands of different tickers across varying styles, strategies, timeframes, and performance profiles. Because not every bot suits every market environment, Tickeron curates a dedicated Trending AI Robots section featuring only the strategies best aligned with current conditions. This selection highlights robots with distinct trading approaches and tracked statistics, helping traders identify candidates that match their own objectives and risk tolerance. Whether you are interested in short-term momentum, swing strategies, or longer-horizon positioning, exploring the Trending AI Robots page can offer a useful starting point for evaluating automated trading options.
Head-to-Head Comparison
Although both companies serve adjacent end markets, their profiles diverge sharply. ECG is a small-cap, high-growth contractor with a roughly $4.5 billion backlog and a valuation near 23x trailing earnings. Its appeal lies in rapid expansion and margin improvement, but its independent operating history is short, and its share price is more volatile than the broader market. PWR, by contrast, is a large-cap with a backlog roughly ten times larger and a trailing price-to-earnings (P/E) ratio well above 70x, reflecting premium expectations already embedded in the stock.
Growth drivers overlap — both benefit from data center electrification, utility hardening, and grid transmission work — yet PWR offers greater diversification across geographies and project types, while ECG offers more concentrated, higher-octane exposure. Risk factors also differ: ECG faces execution and customer-concentration risks typical of a smaller contractor, whereas PWR faces valuation risk and sensitivity to any cooling in large-project awards. In terms of momentum, ECG has shown stronger recent earnings acceleration, while PWR has consolidated after a prolonged advance.
Tickeron AI Verdict
Weighing observable factors such as trend consistency, earnings momentum, backlog growth, and relative positioning, Tickeron's AI would likely favor ECG for near-term relative strength and momentum, given its accelerating revenue and earnings growth, record backlog, and upward guidance revisions. At the same time, the model would recognize PWR's superior stability, scale, and diversification as qualities that may appeal to more risk-averse positioning. The likely probabilistic view is that ECG currently exhibits a more favorable momentum profile, while PWR offers steadier, albeit pricier, exposure to the same secular theme.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECG is a Hold and PWR is a Hold.
ECG in downward trend: 10-day moving average crossed below 50-day moving average on October 15, 2026
The 10-day moving average for ECG crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ECG moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In 13 of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECG as a result. In 26 of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for ECG turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In 11 of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
ECG moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
ECG broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECG advanced for three days, in 98 of 115 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Aroon Indicator entered an Uptrend today. In 115 of 131 cases where ECG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.242) is normal, around the industry mean (15.112). P/E Ratio (22.018) is within average values for comparable stocks, (165.129). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.182) among similar stocks. P/S Ratio (1.335) is also within normal values, averaging (2.926).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ECG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
PWR in downward trend: price dove below 50-day moving average on October 15, 2026
PWR moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend. In 22 of 33 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 67%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for PWR moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 23 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PWR as a result. In 51 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for PWR turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 25 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PWR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
PWR broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for PWR crossed bullishly above the 50-day moving average on October 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +6.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where PWR advanced for three days, in 257 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 276 of 362 cases where PWR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. PWR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.856) is normal, around the industry mean (15.112). P/E Ratio (71.236) is within average values for comparable stocks, (165.129). Projected Growth (PEG Ratio) (1.443) is also within normal values, averaging (3.522). Dividend Yield (0.001) settles around the average of (0.182) among similar stocks. P/S Ratio (2.860) is also within normal values, averaging (2.926).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
PWR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 16 | |
SMR RATING 1..100 | 56 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 32 | |
SEASONALITY SCORE 1..100 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ECG | PWR | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 68% | 4 days ago 57% |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 80% |
| Momentum ODDS (%) | 4 days ago 68% | 4 days ago 64% |
| MACD ODDS (%) | 4 days ago 55% | 4 days ago 50% |
| TrendWeek ODDS (%) | 4 days ago 68% | 4 days ago 62% |
| TrendMonth ODDS (%) | 4 days ago 84% | 4 days ago 77% |
| Advances ODDS (%) | 14 days ago 85% | 14 days ago 74% |
| Declines ODDS (%) | 4 days ago 67% | 4 days ago 60% |
| BollingerBands ODDS (%) | 4 days ago 65% | 4 days ago 52% |
| Aroon ODDS (%) | 4 days ago 88% | 4 days ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ECG’s FA Score shows that 1 FA rating(s) are green while PWR’s FA Score has 2 green FA rating(s).
- ECG’s FA Score: 1 green, 4 red.
- PWR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ECG’s TA Score shows that 3 TA indicator(s) are bullish while PWR’s TA Score has 4 bullish TA indicator(s).
- ECG’s TA Score: 3 bullish, 7 bearish.
- PWR’s TA Score: 4 bullish, 6 bearish.
Price Growth
ECG (@Engineering & Construction) experienced а -10.45% price change this week, while PWR (@Engineering & Construction) price change was -10.49% for the same time period.
The average weekly price growth across all stocks in the @Engineering & Construction industry was -8.31%. For the same industry, the average monthly price growth was -10.49%, and the average quarterly price growth was -23.11%.
Reported Earning Dates
ECG is expected to report earnings on Nov 11, 2026.
PWR is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Engineering & Construction (-8.31% weekly)Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
Advertisement
ECG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ECG has been closely correlated with FIX. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if ECG jumps, then FIX could also see price increases.
| Ticker / NAME | Correlation To ECG | 1D Price Change % | ||
|---|---|---|---|---|
| ECG | 100% | -1.80% | ||
| FIX - ECG | 76% Closely correlated | -2.85% | ||
| PWR - ECG | 72% Closely correlated | -1.61% | ||
| STRL - ECG | 71% Closely correlated | -4.91% | ||
| EME - ECG | 69% Closely correlated | -1.48% | ||
| MYRG - ECG | 67% Closely correlated | -1.89% | ||
More | ||||